Results

1–10 of 38 results for Proliferative Vitreoretinopathy

Phase 3 GUARD Trial of ADX-2191 (Methotrexate for Intravitreal Administration) to Prevent Proliferative Vitreoretinopathy and Other Postoperative Complications
Christina Joy Flaxel, MD
Annual Meeting Talks
2023
Extended Internal Limiting Membrane Peeling for Grade C Proliferative Vitreoretinopathy: International Multicenter Study
Yoshihiro Yonekawa, MD, FASRS
Annual Meeting Talks
2023
Risk of Rhegmatogenous Retinal Detachment With Proliferative Vitreoretinopathy in a Patient's Second Eye After RRD With PVR Development in the First Eye
Emily Shepherd, MD
Annual Meeting Talks
2023
Intravitreal Infliximab for the Treatment of Proliferative Vitreoretinopathy Associated with Rhegmatogenous Retinal Detachment: The Phase II FIXER Trial
Ayman Elnahry, MD, PhD
Annual Meeting Talks
2023
Expert Panel: PVR
Christina Y Weng, MD, MBA, FASRS
Lejla Vajzovic, MD, FASRS
Isabela Martins Melo, MD
Sarah Syeda, MD
Prashant Keshao Bawankule, M.S.
Leo A. Kim, MD, PhD
Annual Meeting Talks
2024
Surgical Case Conference: Ananth Sastry, MD
Ananth Sastry, MD
Annual Meeting Talks
2024
Association of Serum Vitamin D Insufficiency With Proliferative Vitreoretinopathy After Rhegmatogenous Retinal Detachment Repair
Steven D Ness, MD
Updates from the Field
2025
From Bench to Bedside: Investigating the Use of Netarsudil as a Novel Therapeutic Approach for PVR
Leo A. Kim, MD, PhD
Updates from the Field
2025
A Large Break at the Posterior Pole With RD With PVR (S/p Old Blunt Trauma)
Retina Image Bank: Images of the Week
2025
Retinal Massager: New Multifunctional Tool for Vitrectomy
Manish Nagpal, MD, FRCS (UK) ,FASRS
Annual Meeting Talks
2022